非小细胞肺癌N1站淋巴结切除的研究现状  

The research status of the intrapulmonary lymph node dissection in non-small cell lung cancer

作　　者：李子海[1] 张百江[2] 宋平平[2] 

机构地区：[1]济南大学山东省医学科学院医学与生命科学学院,250022 [2]山东大学附属山东省肿瘤医院胸外科,济南250117

出　　处：《中华胸心血管外科杂志》2017年第5期317-320,共4页Chinese Journal of Thoracic and Cardiovascular Surgery

基　　金：山东省重点研发计划（2016GSF201157）;山东省医药卫生科技发展计划（2015WS0148）

摘　　要：外科手术是早期非小细胞肺癌（non-small cell lung cancer,NSCLC）的首选治疗方式,而淋巴结转移是影响可切除NSCLC预后的最重要因素.既往大量研究已确定了系统性纵隔淋巴结（N2）清扫的重要性,也是制定NCCN指南的重要依据.但是肺内淋巴结（N1）清扫少有报道,尤其是非原发肿瘤所在叶、段支气管旁淋巴结的转移未见详细研究,NCCN指南也无详细说明.本文将结合国内外对肺内淋巴结（N1）清扫的相关研究做一综述.Surgery is the first choice for the treatment of early non-small cell lung cancer（NSCLC）,and lymph node metastasis is the most important factor influencing prognosis of resectable NSCLC.A large number of studies have identified the importance of systematic mediastinal lymph node（N2） dissection,which is also an important basis for the development of NCCN guidelines.But there are few reports about the dissection of intrapulmonary lymph node（N1）,especially no detailed study on the dissection of the lymph nodes around the bronchi of non-primary tumor-bearing lobes and segments in lung cancer,and the NCCN guidelines were not detailed elaborate.This article will make a summary of the research on the correlation of intrapulmonary lymph node（N1） dissection.

关 键 词：非小细胞肺癌 N分期 肺内淋巴结清扫 

分 类 号：R734.2[医药卫生—肿瘤]